Literature DB >> 1317111

Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products.

H Asako1, P Kubes, J Wallace, T Gaginella, R E Wolf, D N Granger.   

Abstract

Although the pathogenetic mechanisms underlying indomethacin-induced mucosal injury remain undefined, the results from recent studies suggest that leukocyte adherence in gastric microvessels may be an important component of this injury process. The objective of this study was to determine whether clinically relevant plasma concentrations of indomethacin promote leukocyte-endothelial cell adhesive interactions in postcapillary venules. Erythrocyte velocity, vessel diameter, leukocyte rolling velocity, and the number of adherent (stationary for greater than or equal to 30 s) and emigrated leukocytes were measured in rat mesenteric venules. Repeat measurements of all parameters were obtained within 20 min after addition of either 2.5 or 25 micrograms/ml indomethacin to the mesenteric superfusate. In some experiments, rats were pretreated with either a leukotriene (LT) synthesis inhibitor (L 663,536), an LTD4 (MK-571) or LTB4 (SC 41930) receptor antagonist, misoprostol, or prostacyclin (PGI2). Indomethacin alone increased the number of adherent leukocytes, reduced both leukocyte rolling velocity and venular shear rate, but did not promote leukocyte emigration. L 663,536 and SC 41930 prevented all of the adhesive and hemodynamic alterations induced by indomethacin; misoprostol and PGI2, but not MK-571, exerted similar beneficial effects. These results indicate that indomethacin promotes leukocyte adherence in postcapillary venules through an LTB4-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317111     DOI: 10.1152/ajpgi.1992.262.5.G903

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  40 in total

Review 1.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

2.  Sildenafil prevents indomethacin-induced gastropathy in rats: role of leukocyte adherence and gastric blood flow.

Authors:  Camila L Santos; Marcellus H L P Souza; Antoniella S Gomes; Henrique P Lemos; Armênio A Santos; Fernando Q Cunha; John L Wallace
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  Building a better aspirin: gaseous solutions to a century-old problem.

Authors:  J L Wallace
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

4.  Study on paradoxical effects of NSAIDs on platelet activation.

Authors:  G Andrioli; S Lussignoli; S Gaino; G Benoni; P Bellavite
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

5.  Aloe vera attenuated gastric injury on indomethacin-induced gastropathy in rats.

Authors:  Duangporn Werawatganon; Narisorn Rakananurak; Sasipim Sallapant; Piyapan Prueksapanich; Kanjana Somanawat; Naruemon Klaikeaw; Rungsun Rerknimitr
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

6.  Leukocyte mobilization from the guinea pig spleen by muscarinic cholinergic stimulation.

Authors:  G Sandberg
Journal:  Experientia       Date:  1994-01-15

7.  Mechanisms underlying the anti-inflammatory activity and gastric safety of acemetacin.

Authors:  A E Chávez-Piña; W McKnight; M Dicay; G Castañeda-Hernández; J L Wallace
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

8.  Leucocyte-endothelial cell adhesion in a model of intestinal inflammation.

Authors:  H Arndt; K D Palitzsch; D C Anderson; J Rusche; M B Grisham; D N Granger
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.

Authors:  Koji Takeuchi; Akiko Tanaka; Yujiro Hayashi; Yoshiaki Kubo
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

10.  Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety.

Authors:  A E Chávez-Piña; L Vong; W McKnight; M Dicay; R C O Zanardo; M I Ortiz; G Castañeda-Hernández; J L Wallace
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.